News Conference News ACC 2019 New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin Shelley Wood March 26, 2019
News Daily News Time for Guidelines to Recommend ARBs Over ACE Inhibitors? Shelley Wood March 29, 2018